Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2050 (LINC02050)

Target
LINC02050
Molecular classification
Long non-coding RNA (lncRNA)
01

Overview

Long intergenic non-protein coding RNA 2050 (LINC02050) is classified as a long non-coding RNA (lncRNA). It is a genomic RNA transcript that does not encode a protein and is found on human chromosome 3 (locus 80,764,862-80,868,583). Like other lncRNAs, LINC02050 is presumed to have regulatory functions in gene expression through various potential mechanisms, but there are currently no publications attributing a specific biological role, disease association, or therapeutic targeting potential directly to this transcript. There is no evidence that LINC02050 is a therapeutic target (such as a receptor, enzyme, ion channel, etc.), nor are there drugs known to interact with it, and it is not used as a biomarker in current clinical or experimental settings. LINC02050 is not considered misspelled or incorrect, but it is not a classical drug target according to available data.

Other names
LINC02050Long intergenic non-protein coding RNA 2050ENSG00000242781105377175HGNC:52890
02

Mechanism of action

Not applicable (no drugs or biologic modulators identified)

03

Biological functions

Regulatory RNAlncRNAs like LINC02050 are generally presumed to function in regulation of gene expression at transcriptional and post-transcriptional levels, though there is no specific function attributed to LINC02050 itself in current dataOther (due to lack of specific functional annotation)
04

Disease associations

Other (no specific disease association or therapeutic implication for LINC02050 has been reported)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2050 (LINC02050).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2050 (LINC02050).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call